Global Heart Attack Diagnostics Market

Global Heart Attack Diagnostics Market was valued at USD 14.82 Bn in 2025 and is expected to reach USD 25.73 Bn by 2032, growing at a CAGR of 8.2% during the forecast period.

Heart Attack Diagnostics Market Introduction

A heart attack takes place when the flow of oxygen-rich blood to a section of heart muscle suddenly gets blocked and the heart doesn’t get oxygen. If blood flow isn’t restored quickly, the section of heart muscle dies. According to the Centre for Disease Control and Prevention (CDC)Trusted Source, heart disease is responsible for 1 in 4 four deaths in the United States each year. It’s a leading cause of death in both men and women. The breadth of cardiovascular research is astounding, with research undertaken across a variety of institutions. In the USA, the joint academies developed a document to guide national policy in health with a dedicated document for cardiovascular medicine that includes general directions for research. In Europe, building a roadmap for cardiovascular research is one of the tasks of the ERA-CVD network.To Know About The Research Methodology :- Request Free Sample Report

Heart Attack Diagnostics Market Dynamics

The increasing prevalence of diabetes and hypertension along with the adoption of an unhealthy lifestyle is likely to boost the heart attack diagnosis market growth to a greater extent. As per the Centre for Disease Control and Prevention (CDC)'s National Diabetes Statistics Report, 2022, more than 10.5% of the US population (i.e. 34 million population) has diabetes. Whereas, around 7.3 million people were suffering from diabetes, but have not yet been diagnosed.

Besides the increasing aged population,the increasing obesity among the populationis expected to contribute to the growth of the market during the forecast period. According to the World Health Organization (WHO), in 2022, more than 38.0 million children (under the age of 5 years) were overweight. Once considered a high-income country problem, obesity and overweight are also on the rise in low- and middle-income regions, particularly in urban settings. In African countries, the number of overweight population increased by 24% since 2000. Such an increasing number of obese population will increase the incidences of cardiovascular problems, thereby driving the heart attack diagnosis market growth.

Shortage of skilled workforce in the healthcare industry is a major restraint affecting the growth of the heart attack diagnostics market. According to W.H.O, the world is estimated to experience shortage of 12.9 million medical professionals by 2030. The lack of medical professionals possessing the ability to operate medical devices and conduct diagnostic assessments is anticipated to reduce the demand for such devices in the market.

Heart Attack Diagnostics Market Segment Analysis

In 2025, the Consumables segment shows the highest demand in the Heart Attack Diagnostics Market. Consumables such as reagents, assay kits, and test cartridges are extensively used in blood-based diagnostic procedures, particularly for cardiac biomarker testing like troponin detection. These products are required for every diagnostic test, leading to recurring demand in hospitals and diagnostic laboratories. Instruments, including ECG machines, imaging systems, and diagnostic analyzers, remain essential for cardiac assessment and emergency diagnosis, but their purchasing cycle is longer compared to consumables. Meanwhile, Software & Services are gaining traction as healthcare providers increasingly adopt digital health platforms, data analytics, and diagnostic management systems to enhance diagnostic accuracy and streamline workflow.

Based on Test Type, Electrocardiogram (ECG) is the most widely used diagnostic method for heart attack detection in 2025. ECG is typically the first test performed in emergency situations due to its rapid results and ability to detect abnormal heart rhythms and myocardial damage. Blood Tests, particularly cardiac biomarker tests such as troponin, are also in high demand as they provide accurate confirmation of heart muscle injury. Echocardiogram and Coronary Catheterization (Angiogram) are widely used for further evaluation of heart function and identification of blocked arteries. Advanced imaging techniques such as Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) Scan are increasingly adopted for detailed visualization of cardiac structures and improved diagnostic precision, although they are used more selectively due to higher costs.

Heart Attack Diagnostics Market Regional Insights

Heart Attack Diagnostics Market Report Scope: Inquire before buying

Heart Attack Diagnostics Market: by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Key Players /Competitor Profiles Covered in the Global Heart Attack Diagnostics Market Report from a Strategic Perspective.

1. Abbott Laboratories
2. Siemens Healthineers
3. F. Hoffmann-La Roche Ltd.
4. GE HealthCare
5. Koninklijke Philips N.V.
6. Beckman Coulter Inc.
7. Bio-Rad Laboratories Inc.
8. Thermo Fisher Scientific Inc.
9. bioMérieux SA
10. Randox Laboratories Ltd.
11. QuidelOrtho Corporation
12. Becton Dickinson and Company
13. Nihon Kohden Corporation
14. Nova Biomedical
15. Sysmex Corporation
16. Mindray Medical International Limited
17. Response Biomedical Corp.
18. Critical Diagnostics
19. Luminex Corporation
20. PerkinElmer Inc.
21. Cardinal Health Inc.
22. Medtronic plc
23. Boston Scientific Corporation
24. AliveCor Inc.
25. Schiller AG